Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 181 AL 195

Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function

Hertz L, Chen Y, Waagepetersen HS.

J Neurochem. 2015 Jul;134(1):7-20. doi: 10.1111/jnc.13107. Epub 2015 Apr 23.

Rivastigmine for Alzheimer's disease

Birks JS, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Apr 10;(4):CD001191. doi: 10.1002/14651858.CD001191.pub3.

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

Matsunaga S, Kishi T, Iwata N.

PLoS One. 2015 Apr 10;10(4):e0123289. doi: 10.1371/journal.pone.0123289. eCollection 2015.

Effects of physical activity training in patients with Alzheimer's dementia: results of a pilot RCT study

Holthoff VA, Marschner K, Scharf M, Steding J, Meyer S, Koch R, Donix M.

PLoS One. 2015 Apr 17;10(4):e0121478. doi: 10.1371/journal.pone.0121478. eCollection 2015.

Latrepirdine for Alzheimer's disease

Chau S, Herrmann N, Ruthirakuhan MT, Chen JJ, Lanctôt KL.

Cochrane Database Syst Rev. 2015 Apr 21;2015(4):CD009524. doi: 10.1002/14651858.CD009524.pub2.

The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial

Chua KK, Wong A, Kwan PW, Song JX, Chen LL, Chan AL, Lu JH, Mok V, Li M.

Trials. 2015 Apr 30;16:199. doi: 10.1186/s13063-015-0716-z.

Object recognition test for studying cognitive impairments in animal models of Alzheimer's disease

Bengoetxea X, Rodriguez-Perdigon M, Ramirez MJ.

Front Biosci (Schol Ed). 2015 Jun 1;7(1):10-29. doi: 10.2741/S421.

Depression associated with dementia

Gutzmann H, Qazi A.

Z Gerontol Geriatr. 2015 Jun;48(4):305-11. doi: 10.1007/s00391-015-0898-8. Epub 2015 May 12.

Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease

Lenz RA, Pritchett YL, Berry SM, Llano DA, Han S, Berry DA, Sadowsky CH, Abi-Saab WM, Saltarelli MD.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):192-9. doi: 10.1097/WAD.0000000000000093.

Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature

Defrancesco M, Marksteiner J, Fleischhacker WW, Blasko I.

Int J Neuropsychopharmacol. 2015 May 19;18(10):pyv055. doi: 10.1093/ijnp/pyv055.

[How to recognize pain in patients with dementia]

Kunz M, Lautenbacher S.

MMW Fortschr Med. 2015 May 28;157(10):72-4. doi: 10.1007/s15006-015-3140-0.

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease

Deardorff WJ, Feen E, Grossberg GT.

Drugs Aging. 2015 Jul;32(7):537-47. doi: 10.1007/s40266-015-0273-x.

The Effect of Memantine on Cognitive Function and Behavioral and Psychological Symptoms in Mild-to-Moderate Alzheimer's Disease Patients

Zhang N, Wei C, Du H, Shi FD, Cheng Y.

Dement Geriatr Cogn Disord. 2015;40(1-2):85-93. doi: 10.1159/000430808. Epub 2015 Jun 5.

Factors Associated with Greater Adherence to and Satisfaction with Transdermal Rivastigmine in Patients with Alzheimer's Disease and Their Caregivers

Riepe M, Weinman J, Osae-Larbi J, Mulick Cassidy A, Knox S, Chaves R, Müller B.

Dement Geriatr Cogn Disord. 2015;40(1-2):107-19. doi: 10.1159/000381894. Epub 2015 Jun 5.

Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials

Zis P, Mitsikostas DD.

J Neurol Sci. 2015 Aug 15;355(1-2):94-100. doi: 10.1016/j.jns.2015.05.029. Epub 2015 May 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias